{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T23:10:21Z","timestamp":1735686621540,"version":"3.32.0"},"reference-count":100,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:p>A doen\u00e7a meningoc\u00f3cica continua sendo um grande problema de sa\u00fade p\u00fablica em todos os continentes, e as vacinas anti-meningoc\u00f3cicas t\u00eam sido indicadas na preven\u00e7\u00e3o e controle de epidemias. As vacinas polissacar\u00eddicas A e C s\u00e3o relativamente eficazes, com comportamentos imunol\u00f3gicos distintos frente \u00e0s faixas et\u00e1rias; no entanto, para o sorogrupo B, embora existam numerosos estudos internacionais at\u00e9 agora j\u00e1 desenvolvidos, ainda n\u00e3o se tem uma vacina altamente segura e eficaz de ampla aceita\u00e7\u00e3o. O polissac\u00e1ride capsular do meningococo B n\u00e3o \u00e9 imunog\u00eanico devido ao seu mimetismo com componentes celulares do hospedeiro. Tentativas de se introduzir carreadores prot\u00e9icos v\u00eam sendo feitas para se obter uma vacina que seja imunog\u00eanica em todas as faixas et\u00e1rias e de prefer\u00eancia protetora contra todos os meningococos. Foi feita revis\u00e3o da literatura com o objetivo de estudar o comportamento imunol\u00f3gico de todas as vacinas, at\u00e9 ent\u00e3o desenvolvidas, e mostrar os esfor\u00e7os que est\u00e3o sendo empreendidos no sentido de se buscar um produto seguro e eficaz para o controle da doen\u00e7a meningoc\u00f3cica<\/jats:p>","DOI":"10.1590\/s0034-89101997000400010","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T14:14:22Z","timestamp":1114611262000},"page":"402-416","source":"Crossref","is-referenced-by-count":1,"title":["Comportamento imunol\u00f3gico das vacinas anti-meningoc\u00f3cicas"],"prefix":"10.1590","volume":"31","author":[{"given":"Henry I. Z.","family":"Requejo","sequence":"first","affiliation":[{"name":"Instituto Adolfo Lutz"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/02724936.1994.11747729","article-title":"Reactogenicity and safety of meningococcal A and C vaccine in Saudi children","volume":"14","author":"AL-EISSA Y.A.","year":"1994","journal-title":"Ann. Trop. Paediatr."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/JCM.15.2.324-329.1982","article-title":"Identification of immunoglobulin heavy-chain isotypes of specific antibodies of horse 46 group B meningococcal antiserum","volume":"15","author":"ALLEN P.Z.","year":"1982","journal-title":"J. Clin. Microbiol.","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref3","first-page":"317","article-title":"Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine","volume":"61","author":"AMBROSCH F.","year":"1983","journal-title":"Bull. WHO"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/IAI.62.8.3391-3395.1994","article-title":"Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults","volume":"62","author":"ANDERSON E.L","year":"1994","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref5","first-page":"201","article-title":"Reactogenicity and immunogenicity of a tetravalent meningococcal vaccine in different age groups","volume":"43","author":"ANDRE F.E.","year":"1983","journal-title":"Med. Trop."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine","volume":"282","author":"ARTENSTEIN M.S.","year":"1970","journal-title":"N. Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0264-410X(94)00007-A","article-title":"Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide","volume":"13","author":"BARTOLONI A.","year":"1995","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0264-410X(93)90236-Q","article-title":"Dramatic redution of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination","volume":"11","author":"BISELLI R.","year":"1993","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"BJUNE G.","year":"1991","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile","volume":"13","author":"BOSLEGO J.","year":"1995","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/infdis\/137.2.202","article-title":"Immunogenicity of serogroup A and C Neisseria meningitidis polysaccharide vaccines administered together in humans","volume":"137","author":"BRANDT B.L.","year":"1978","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":":4996","DOI":"10.1021\/bi00136a012","article-title":"Helical epitope of the group B meningococcal alpha-(2<img src=\"http:\/img\/fbpe\/rsp\/v31n4\/2289.h20.jpg\" alt=\"wpe28.jpg (727 bytes)\" align=\"middle\">8)-linked sialic acid polysaccharide","volume":"31","author":"BRISSON J.R.","journal-title":"Biochemistry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-2960","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(85)90266-X","article-title":"Tetravalent (A, C, Y, W135) meningococcal vaccine in children: immunogenicity and safety","volume":"3","author":"CADOZ M.","year":"1985","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/infdis\/167.5.1212","article-title":"Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization","volume":"167","author":"CEESAY S.J.","year":"1993","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref15","first-page":"381","article-title":"Meningococcal polysaccharide vaccines","volume":"24","year":"1975","journal-title":"M.M.W.R."},{"key":"ref16","first-page":"28S","article-title":"Inactivated-bacteria vaccines: Meningococcal disease","volume":"33","year":"1984","journal-title":"M.M.W.R."},{"key":"ref17","first-page":"119","article-title":"Epidemic meningococcal disease: recommendations for Travelers to Nepal","volume":"34","year":"1985","journal-title":"M.M.W.R."},{"key":"ref18","first-page":"255","article-title":"Meningococcal vaccines","volume":"34","year":"1985","journal-title":"M.M.W.R."},{"key":"ref19","first-page":"1","article-title":"Epidemic meningococcal disease - Kenya and Tanzania: recommendations for travelers, 1990","volume":"39","year":"1990","journal-title":"M.M.W.R."},{"key":"ref20","first-page":"763","article-title":"Availability of meningococcal vaccine in single-dose vials for travelers and high-risk persons","volume":"39","year":"1990","journal-title":"M.M.W.R."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(92)90091-W","article-title":"Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C","volume":"10","author":"CONSTANTINO P.","year":"1992","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"issue":"2","key":"ref22","first-page":"35","article-title":"Efic\u00e1cia da vacina antimeningoc\u00f3cica (VA-MENGOC BC) nas condi\u00e7\u00f5es de uso no Brasil, no per\u00edodo 1989\/90","volume":"3","author":"COSTA E.A.","year":"1995","journal-title":"Inf. Epidemiol. SUS","ISSN":"https:\/\/id.crossref.org\/issn\/0104-1673","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1590\/S0034-89101996000500009","article-title":"Avalia\u00e7\u00e3o da prote\u00e7\u00e3o conferida pela vacina antimeningoc\u00f3cica BC no Estado de Santa Catarina, Brazil, 1990\/92","volume":"30","author":"COSTA E.A","year":"1996","journal-title":"Rev. Sa\u00fade P\u00fablica","ISSN":"https:\/\/id.crossref.org\/issn\/0034-8910","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1574-695X.1996.tb00067.x","article-title":"Human immune response to epitopes on the meningococcal outer membrane class 5 protein following natural infection FEMS","volume":"15","author":"DANELLI M.G.M.","year":"1996","journal-title":"Immunol. Med. Microbiol."},{"key":"ref25","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1073\/pnas.88.16.7175","article-title":"Antibodies to poly-(2-8)-alpha-N-acetylneuraminic acid and poly-alpha-(2-9)-N-acetylneuraminic acid are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1","volume":"88","author":"DEVI S.J.N.","year":"1991","journal-title":"Proc. Natl. Acad. Sci.","ISSN":"https:\/\/id.crossref.org\/issn\/0027-8424","issn-type":"print"},{"key":"ref26","first-page":"301","article-title":"A serogroup A meningococcal polysaccharide vaccine: Studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A","volume":"49","author":"ERWA H.H.","year":"1973","journal-title":"Bull. WHO."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/174.6.1360","article-title":"Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants","volume":"174","author":"FAIRLEY C.K.","year":"1996","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3181\/00379727-157-39995","article-title":"Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C and Y","volume":"157","author":"FARQUHAR J.D.","year":"1978","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1084\/jem.144.2.319","article-title":"Protection against group B meningococcal disease: I. Comparison of group-specific and type-specific protection in the chick embryo model","volume":"144","author":"FRASCH C.E.","year":"1976","journal-title":"J. Exp. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1007","issn-type":"print"},{"key":"ref30","first-page":"177","article-title":"Development and evaluation of group B serotype 2 protein vaccines: report of a group B field trial","volume":"43","author":"FRASCH C.E.","year":"1983","journal-title":"Med. Trop."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00415493","article-title":"Appearance of new strains associated with group B meningococcal disease and their use for rapid vaccine development","volume":"53","author":"FRASCH C.E.","year":"1987","journal-title":"Antonie van Leeuwenhoek","ISSN":"https:\/\/id.crossref.org\/issn\/0003-6072","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0264-410X(87)90002-8","article-title":"Prospects for the prevention of meningococcal disease: special reference to group B","volume":"5","author":"FRASCH C.E.","year":"1987","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00555244","article-title":"Study Group of Meningitis: Preliminary results from a clinical trail with a meningococcal vaccine containing serotype 2b and 15 antigens in complex with mixed A, C, Y and W135 polisaccharides","volume":"52","author":"FROHOLM L.O.","year":"1986","journal-title":"Antonie van Leeuwenhoek","ISSN":"https:\/\/id.crossref.org\/issn\/0003-6072","issn-type":"print"},{"key":"ref34","first-page":"1","article-title":"Meningococcal disease and its control with meningococcal polysaccharide vaccines","volume":"60","author":"GALAZKA A.","year":"1982","journal-title":"Bull. WHO."},{"key":"ref35","first-page":"279","article-title":"Meningococcal infections: 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70","volume":"45","author":"GOLD R.","year":"1971","journal-title":"Bull. WHO."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI108235","article-title":"Clinical evaluation of group A and C meningococcal polysaccharide in infants","volume":"56","author":"GOLD R","year":"1975","journal-title":"J. Clin. Invest.","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9738","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0065-3101(22)00718-6","article-title":"Present status of polysaccharide vaccines in the prevention of meningococcal disease","volume":"23","author":"GOLD R","year":"1976","journal-title":"Adv. Pediatr."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/infdis\/125.5.509","article-title":"Immunogenicity of the group A and group C meningococcal polysaccharides in children","volume":"125","author":"GOLDSCHNEIDER I.","year":"1972","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref39","first-page":"509","article-title":"Prospects for the prevention of bacterial meningitis with polysaccharide vaccines","volume":"56","author":"GOTSCHLICH E.C.","year":"1978","journal-title":"Bull. WHO."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8915","DOI":"10.1016\/S0021-9258(19)52486-3","article-title":"Lipid on capsular polysaccharides of gram-negative bacteria","volume":"256","author":"GOTSCHLICH E.C.","year":"1981","journal-title":"J. Biol. Chem.","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/IAI.34.3.725-732.1981","article-title":"Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults","volume":"34","author":"GRIFFISS J.M.","year":"1981","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/IAI.39.1.247-252.1983","volume":"39","author":"GRIFFISS J.M.","year":"1983","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/00365548909035696","volume":"21","author":"HALSTENSEN A.","year":"1989","journal-title":"Scand. J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0036-5548","issn-type":"print"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2105\/AJPH.85.6.843","article-title":"Should college students be vaccinated against meningococcal disease?: A cost-benefit analysis","volume":"85","author":"JACKSON L.A.","year":"1995","journal-title":"Am. J. Public. Health"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.4049\/jimmunol.134.4.2651","article-title":"Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis","volume":"134","author":"JENNINGS H.J.","year":"1985","journal-title":"J. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.4049\/jimmunol.137.5.1708","article-title":"Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine","volume":"137","author":"JENNINGS H.J.","year":"1986","journal-title":"J. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1767","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1084\/jem.165.4.1207","article-title":"N-propionylated group B meningococcal polysaccharide mimics a unique epitope on group B Neisseria meningitidis","volume":"165","author":"JENNINGS H.J.","year":"1987","journal-title":"J. Exp. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1007","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/infdis\/142.6.861","article-title":"Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children","volume":"142","author":"KAYHTY H.","year":"1980","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0022-3476(96)70389-X","article-title":"Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children","volume":"128","author":"KING W.J.","year":"1996","journal-title":"J. Pediatr.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1699-0463.1991.tb01258.x","article-title":"Immunization against serogroup B meningococci: Opsonin response in vaccines as measured by chemiluminescence","volume":"99","author":"LEHMANN A.K.","year":"1991","journal-title":"Acta Pathol Microbiol. Immnol. Scand."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2249.1991.tb05661.x","article-title":"Clonotypic analysis of human antibodies specific for Neisseria meningitidis polysaccharides A and C in adults","volume":"83","author":"LE MOLI S.","year":"1991","journal-title":"Clin. Exp. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"ref52","first-page":"617","article-title":"Successful intevention in a group: A meningococcal outbreak in Auckland, New Zealand","volume":"11","author":"LENNON D.","year":"1992","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref53","first-page":"3","article-title":"Control of epidemic group: A meningococcal disease in Auckland","volume":"5","author":"LENNON D.","year":"1993","journal-title":"New Zealand Med. J."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1542\/peds.60.5.673","article-title":"Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines","volume":"60","author":"LEPOW M.L.","year":"1977","journal-title":"Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1128\/IAI.63.7.2645-2651.1995","article-title":"Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes","volume":"63","author":"LETT E.","year":"1995","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0264-410X(91)90318-Z","article-title":"Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins","volume":"9","author":"LIFELY M.R.","year":"1991","journal-title":"Vaccine","ISSN":"https:\/\/id.crossref.org\/issn\/0264-410X","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1016\/S0021-9258(18)61992-1","article-title":"Studies on the meningococcal polysaccharides: II. Composition and chemical properties of the group B and group C polysaccharides","volume":"246","author":"LIU T.Y.","year":"1971","journal-title":"J. Biol. Chem.","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9258","issn-type":"print"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1128\/IAI.57.5.1590-1598.1989","article-title":"Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination","volume":"57","author":"MANDRELL R.E.","year":"1989","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1590\/S0034-89101993000300012","article-title":"Imunidade conferida por vacinas anti-meningoc\u00f3cicas","volume":"27","author":"MILAGRES L.G.","year":"1993","journal-title":"Rev. Sa\u00fade P\u00fablica","ISSN":"https:\/\/id.crossref.org\/issn\/0034-8910","issn-type":"print"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"MILAGRES L.G.","year":"1994","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"issue":"2","key":"ref61","first-page":"7","article-title":"Relat\u00f3rio sobre a avalia\u00e7\u00e3o da efic\u00e1cia da vacina antimeningoc\u00f3cica BC de origem cubana","volume":"3","year":"1995","journal-title":"Inf. Epidemiol. SUS","ISSN":"https:\/\/id.crossref.org\/issn\/0104-1673","issn-type":"print"},{"key":"ref62","article-title":"Control of epidemic meningococcal meningitis by mass vaccination","volume":"2","author":"MOHAMMED I.","year":"1981","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in S\u00e3o Paulo, Brazil","volume":"340","author":"MORAES J.C.","year":"1992","journal-title":"Lancet,","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref64","first-page":"149","article-title":"Evaluacion serologica de la vacina antimeningococica polivalente A-C en Chile","volume":"93","author":"MORENO J.G.","year":"1982","journal-title":"Bol. Of. Sanit. Panam.","ISSN":"https:\/\/id.crossref.org\/issn\/0030-0632","issn-type":"print"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/mpat.1995.0033","article-title":"Heterologous production of the P1 porin of Neisseria meningitidis in Bacillus subtilis: the effect of an N-terminal extension on the presentation of native-like epitopes","volume":"18","author":"MUTTILAINEN S.","year":"1995","journal-title":"Microbial Pathog."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/mpat.1995.0038","article-title":"The Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis and reconstituted into phospholipid vesicles elicits antibodies to native P1 epitopes","volume":"18","author":"MUTTILAINEN S.","year":"1995","journal-title":"Microbial Pathog."},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/24.5.1050","article-title":"Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study","volume":"24","author":"NORONHA C.P","year":"1995","journal-title":"Intern. J. Epidemiol."},{"key":"ref68","doi-asserted-by":"crossref","first-page":"F43","DOI":"10.1136\/fn.74.1.F43","article-title":"Meningococcal antibody titres in infants of women immunised with meningococcal polysaccharide vaccine during pregnancy","volume":"74","author":"O\u2019DEMPSEY T.J.D.","year":"1996","journal-title":"Arch. Dis. Child.","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9888","issn-type":"print"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"PELTOLA H.","year":"1977","journal-title":"N. Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/clinids\/5.1.71","article-title":"Meningococcal disease: still with us","volume":"5","author":"PELTOLA H.","year":"1983","journal-title":"Rev. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0162-0886","issn-type":"print"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archpedi.1994.02170060074015","article-title":"Clinical comparison of the Haemophilus influenzae type b polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy","volume":"148","author":"PELTOLA H.","year":"1994","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"ref72","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/infdis\/166.2.359","volume":"166","author":"PINNER R.W.","year":"1992","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.1995.tb03600.x","article-title":"Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine","volume":"100","author":"PLATONOV A.E.","year":"1995","journal-title":"Clin. Exp. Immunol.","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/infdis\/157.1.118","article-title":"Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections","volume":"157","author":"RAFF H.V.","year":"1988","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref75","first-page":"111","article-title":"Evaluation of antibody response in meningococcal patients, contacts and vaccinees in North India","volume":"43","author":"RAO B.","year":"1991","journal-title":"Trop. Geogr. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0041-3232","issn-type":"print"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0140-6736(85)90224-7","article-title":"Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine","volume":"2","author":"REINGOLD A.L.","year":"1985","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref77","first-page":"98","article-title":"Neisseria meningitidis: an\u00e1lise dos ant\u00edgenos de membrana externa e distribui\u00e7\u00e3o geogr\u00e1fica dos sorotipos e subtipos","volume":"103","author":"REQUEJO H.I.Z.","year":"1996","journal-title":"LAES-HAES"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.131.3.499","article-title":"The relationship between group A and C meningococcal polysaccharides and serum opsonins in man","volume":"131","author":"ROBERTS R.B.","year":"1970","journal-title":"J. Exp. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1007","issn-type":"print"},{"year":"1989","series-title":"Imunologia","author":"ROITT I.","key":"ref79"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/JCM.26.8.1543-1548.1988","article-title":"Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection","volume":"26","author":"ROSENQVIST E.","year":"1988","journal-title":"J. Clin. Microbiol.","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/infdis\/167.5.1065","article-title":"The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies","volume":"167","author":"ROSENQVIST E.","year":"1993","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/infdis\/155.6.1266","article-title":"Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals","volume":"155","author":"ROSS S.C.","year":"1987","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"first-page":"909","year":"1994","author":"SIERRA V.G.","key":"ref83"},{"key":"ref84","first-page":"429","article-title":"Disease prevention by meningococcal serogroup C polysaccharide vaccine in preschool children","volume":"8","author":"TAUNAY A.E.","year":"1974","journal-title":"Pediatr. Rev."},{"key":"ref85","first-page":"21","article-title":"Aspectos etiol\u00f3gicos da doen\u00e7a meningoc\u00f3cica","volume":"11","author":"TAUNAY A.E.","year":"1975","journal-title":"Atual. Med."},{"key":"ref86","doi-asserted-by":"crossref","first-page":"77","DOI":"10.53393\/rial.1978.38.37124","article-title":"Avalia\u00e7\u00e3o do efeito protetor de vacina polissacar\u00eddica antimeningoc\u00f3cica do grupo C, em crian\u00e7as de 6 a 36 meses","volume":"38","author":"TAUNAY A.E.","year":"1978","journal-title":"Rev. Inst. Adolfo Lutz","ISSN":"https:\/\/id.crossref.org\/issn\/0073-9855","issn-type":"print"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/infdis\/171.3.632","article-title":"A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants","volume":"171","author":"TWUMASI Jr P.A.","year":"1995","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref88","first-page":"285","article-title":"Study Group of Meningococcal Vaccines: Respuesta inmune humoral a las prote\u00ednas de una vacuna antimeningoc\u00f3cica BC en un ensayo realizado en Antioquia, Colombia","volume":"118","author":"URIBE M.L.E.","year":"1995","journal-title":"Bol. Ofic. Sanit. Panan."},{"key":"ref89","first-page":"295","article-title":"Study Group of Meningococcal Vaccines: Respuesta inmune humoral al polisac\u00e1rido capsular de Neisseria meningitidis serogroup C en un ensayo de vacunaci\u00f3n antimeningoc\u00f3cica BC en Antioquia, Colombia","volume":"118","author":"URIBE M.L.E.","year":"1995","journal-title":"Bol. Ofic. Sanit. Panan."},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1128\/IAI.64.7.2745-2751.1996","article-title":"Specificity of human bactericidal antibodies against Por A P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine","volume":"64","author":"van der VOORT E.R.","year":"1996","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref91","first-page":"667","article-title":"A controllled field trial of a serogroup A meningococcal polysaccharide vaccine","volume":"46","author":"WAHDAN M.H.","year":"1973","journal-title":"Bull. WHO"},{"key":"ref92","first-page":"645","article-title":"A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria","volume":"55","author":"WAHDAN M.H.","year":"1977","journal-title":"Bull. WHO."},{"key":"ref93","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.46.2.408-414.1984","article-title":"Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model","volume":"46","author":"WANG L.Y.","year":"1984","journal-title":"Infect. Immun.","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"first-page":"940","year":"1994","author":"WANG L.Y.","key":"ref94"},{"key":"ref95","first-page":"503","article-title":"Adverse events temporally associated with meningococcal vaccines","volume":"154","author":"YERGEAU A.","year":"1996","journal-title":"Can. Med. Assoc. J."},{"key":"ref96","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/169.4.847","article-title":"Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel","volume":"169","author":"ZANGWILL K.M.","year":"1994","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/infdis\/137.6.728","article-title":"Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans","volume":"137","author":"ZOLLINGER W.D.","year":"1978","journal-title":"J. Infect. Dis.","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF00415494","article-title":"Human bactericidal antibody response to meningococcal outer membrane protein vaccines","volume":"53","author":"ZOLLINGER W.D.","year":"1987","journal-title":"Antonie van Leewenhoek"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0035-9203(91)90339-Z","article-title":"Meningococcal vaccines: present and future","volume":"85","author":"ZOLLINGER W.D.","year":"1991","journal-title":"Royal Soc. Trop. Med. Hyg."},{"key":"ref100","first-page":"211","article-title":"The Chilean National Committee for Meningococcal Disease: Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile","volume":"14","author":"ZOLLINGER W.D.","year":"1991","journal-title":"NIPH Ann."}],"container-title":["Revista de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsp\/v31n4\/2289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T22:44:38Z","timestamp":1735685078000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-89101997000400010&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["S0034-89101997000400010"],"URL":"https:\/\/doi.org\/10.1590\/s0034-89101997000400010","relation":{},"ISSN":["0034-8910"],"issn-type":[{"type":"electronic","value":"0034-8910"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}